Neuroimaging

Although the COVID-19 pandemic has profoundly disrupted many research studies, it has also accelerated development and use of remote assessment tools for cognition. The UCSF Brain Health Registry (BHR), an online research registry of over 100,000 adult volunteers, has been an innovator in this area and has continued to move forward.

April is Parkinson's Awareness Month! Finding a cure might take time but through advanced neuroimaging research we can improve the quality of life for people with Parkinson's and their families.

Olga Tymofiyeva, PhD, along with her colleagues, embarked on the quest of trying to understand of the brain mechanisms that underlie potential smartphone dependence. The full article can be found in Frontiers in Human Neuroscience.

Alzheimer's disease (AD) is defined as amyloid plaques, tau tangles and degeneration of nerve cells in the brain leading to memory problems, cognitive decline and dementia. Currently, there are no treatments which slow the progression of AD, but a number of treatments are in late-stage clinical trials and some appear promising.

A new study from investigators at UCSF Radiology reviewed the current literature on neuroradiological findings in SARS-CoV-2 patients to identify latent patterns and trends that could be useful in guiding clinical management of these patients.